Health Condition 1: G891- Acute pain, not elsewhere classified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Bupivacaine with Dexmedetomidine is added to one of the group. Dexmedetomidine , an alpha 2 adrenergic agonist, is believed to work by inhibiting the release of
Sponsors
Dr Kairavi Ranipa
Eligibility
Inclusion criteria
Inclusion criteria: Age between 18 and 65 years either sex American society of Anaesthesiologist Physical status 1 or 2 Able to understand the study protocol and willing to provide written informed consent
Exclusion criteria
Exclusion criteria: Pregnent and Lactating women Body Mass Index more than 30 Patient taking regular analgesic or antidepressant or antiepileptic History of drug allergy Coagulopathy disorder Infection at site of injection Patient refusal Uncontrolled HTN or DM or Cardiovascular otr Cerebrovascular or Endocrine or Renal or Liver disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the efficacy of Bupivacaine alone,Bupivacaine + Dexmedetomidine and Normal saline in Sphenopalatine ganglion block in patient undergoing FESSTimepoint: After 2 hours,4 hours, 8 hours, 12 hours and 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: | — |
Countries
India
Contacts
Public ContactDr Vandana Parmar
Pdu civil hospital Rajkot
Outcome results
None listed